Korean J Med > Volume 70(2); 2006 > Article
The Korean Journal of Medicine 2006;70(2):138-144.
Han Kyu Lee, Young Mo Lee, Joo Kyoung Song, Sa Rah Jeong, Soo Yoon Lee, Dong Seok Jang, Oh Kyung Kwon, Ki Ryang Na, Kang Wook Lee, Young Tai Shin
전남대학교 의과대학 내과학교실
원저 : 투석 전 만성신부전 환자의 신기능에 대한 Erythropoietin의 효과 (Original Articles : Efficacy of erythropoietin in renal function of pre-dialysis patients with chronic renal failure)
이한규, 이영모, 송주경, 정사라, 이수윤, 장동석, 권오경, 나기량, 이강욱, 신영태
Abstract
Background : Anemia is one of the most important risk factors for cardiovascular morbidity and mortality in patients with chronic renal failure. The most effective treatment modality for anemia is erythropoietin injection. Besides erythropoietic effect, erythropoietin has multiple beneficial effects such as anti-oxidant, anti-hypoxic, anti-apoptotic and vasculogenetic effects, and prevents tubular lesions and interstitial fibrosis. Despite lots of advantages of erythropoietin therapy, the number of patients treated with this agent is modest, particularly during the pre-dialysis chronic renal failure. We conducted a clinical trial to evaluate the effects of erythropoietin on renal function in the anemic pre-dialysis patients with chronic renal failure.
Methods
: Data of 23 pre-dialysis patients with chronic renal failure were analyzed retrospectively 6 months prior, and prospectively 6 months after the initiation of erythropoietin therapy. Erythropoietin was admitted at a dose of 3000 IU weekly with supplementary iron.
Results
: The average hematocrit and hemoglobin rose from 22.1¡¾2.5%, 7.4¡¾0.8 g/dL to 28.4¡¾ 4.2%, 9.6¡¾1.5 g/dL, respectively. When linear regression analysis was applied to pre- and post-erythropoietin glomerular filtration rate and 1/Cr, mean rate of decline of glomerular filtration rate were significantly delayed (p=0.039) but that of 1/Cr had a tendency to be delayed but was not statistically meaningful (p=0.099).
Conclusions
: Treatment of the anemia with low dose erythropoietin in pre-dialysis patients with chronic renal failure is relatively safe and may slow the rate of renal function deterioration.(Korean J Med 70:138-144, 2006) Key Words : Erythropoietin, Pre-dialysis patients, Chronic renal failure
Key Words: Erythropoietin, Pre-dialysis patients, Chronic renal failure


TOOLS
METRICS Graph View
  • 1,301 View
  • 14 Download

Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6791    Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr                

Copyright © 2024 by The Korean Association of Internal Medicine.

Developed in M2PI

Close layer
prev next